相关实验视频

Updated: Mar 11, 2026

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent

Published on: September 3, 2013

脂友群改性Gd-PCTA作为一种高性能MRI对比剂,具有动态惰性,蛋白质结合性和增强的轻松性

Sangyun Lee¹, Ah Rum Baek², Bokyung Sung²

¹Department of Medical & Biological Engineering, Kyungpook National University, Daegu 419944, Korea.

Journal of medicinal chemistry

|March 9, 2026

概括

一种新的基于加多的对比剂Gd-PCTA-Ach为MRI扫描提供了更高的安全性和有效性. 它的优越性质和瘤可视化能力表明,它有望改善诊断效用.

科学领域:

医疗成像医学成像
放射化学放射化学是指辐射化学.
材料科学材料科学材料科学

背景情况:

基于加多的对比剂 (GBCA) 对于磁共振成像 (MRI) 非常重要.
对于更安全,更有效的GBCA,具有更好的稳定性和诊断性能的持续需求.
现有的GBCA面临与安全性和疗效相关的挑战.

研究的目的:

开发一种新的宏环加多复合物,Gd-PCTA-Ach,具有对MRI的增强特性.
评估Gd-PCTA-Ach的放松性,运动惰性和药理动力学特征.
评估Gd-PCTA-Ach在临床前瘤模型中的体内诊断效用.

主要方法:

新型宏环复合物Gd-PCTA-Ach. 的合成和表征.
测量放松性 (r1和r2) 和运动惰性.
对专蛋白结合亲和力和药理动力学研究的评估.
在脑和肝脏瘤小鼠模型中的体内权重MRI.

主要成果:

与已批准的药物相比,Gd-PCTA-Ach表现出优越的放松性 (r1 = 13.6,r2 = 15.8 mM-1) 和运动惰性.
增强的脂性导致中度的白蛋白亲和力 (34.8%) 和延长的循环时间.
在体内研究证实了初级清除与部分肝胆排泄 (约. 10%) 的情况.
在大脑和肝脏模型中成功可视化瘤病变.

结论:

Gd-PCTA-Ach 是一种高效且稳定的MRI对比剂.
它有利的药理动力学特征和有效的瘤可视化表明其具有广泛的诊断效用.
Gd-PCTA-Ach有可能成为当前GBCA的更安全,更有效的替代品.

更多相关视频

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Preparation and In Vitro Characterization of Dendrimer-based Contrast Agents for Magnetic Resonance Imaging

Published on: December 4, 2016

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Investigations on the GaIII Complex of EOB-DTPA and Its 68Ga Radiolabeled Analogue

Published on: August 17, 2016

相关概念视频

Magnetic Resonance Imaging

Magnetic Resonance Imaging

Magnetic resonance imaging (MRI) is a noninvasive medical imaging technique based on a phenomenon of nuclear physics discovered in the 1930s, in which matter exposed to magnetic fields and radio waves was found to emit radio signals. In 1970, a physician and researcher named Raymond Damadian noticed that malignant (cancerous) tissue gave off different signals than normal body tissue. He applied for a patent for the first MRI scanning device in clinical use by the early 1980s. The early MRI...

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT)

Insensitive Nuclei Enhanced by Polarization Transfer (INEPT) is an advanced Nuclear Magnetic Resonance (NMR) technique specifically designed to detect and enhance the signals of low-abundance nuclei, such as carbon-13 and nitrogen-15, in small molecules. The fundamental principle behind INEPT is the transfer of polarization from a more abundant and highly polarizable nucleus, typically hydrogen-1, to the low-abundance nucleus of interest. This process effectively boosts the NMR signal of the...